
Dynocardia Inc Profile last edited on: 2/15/2023
CAGE: 87W08
UEI: HMN7FWLXJ1H4
Business Identifier: Direct, beat-to-beat measurement of blood pressure: wrist-wearable Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 07
County: Middlesex
Congr. District: 07
County: Middlesex
Public Profile
Dynocardia is a biomedical device development company structured around addressing critical unmet needs to improve healthcare. The firm's lead diagnostic device - ViTrack - is powered by the firm's proprietary technology making it the only stand-alone, cuff-less device that allows for continuous, non-invasive blood pressure (cNIBP) measurement. In contrast to conventional occlusive devices, ViTrack offers direct, beat-to-beat measurement of blood pressure that is wrist-wearable, mobile, and easy to use, with the accuracy of intra-arterial lines. With data-rich capability that includes heart rate, heart rhythm, and respiratory parameters in addition to blood pressure, the firm's defeloped device enables early intervention prior to acute events. Originally located in Lowell MA (at time of application/award) the firm appears to have relocated to the Cambridge MA innovation Center,
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
10-14Revenue Range
1M-1.5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2024 | 2 | NIH | $2,425,925 | |
Project Title: ViTrack: Wearable, accurate, continuous blood pressure monitor to improve outcomes in hypertensive diseases of pregnancy | ||||
2022 | 1 | NSF | $256,000 | |
Project Title: Motion artifact management for accurate and continuous non-invasive blood pressure monitoring | ||||
2022 | 2 | NIH | $2,144,153 | |
Project Title: Development of a novel cuff-less wrist wearable continuous blood pressure monitor |
Key People / Management
Mohan Thanikachalam -- CEO, President, and Co-Founder
Edward Adelson -- Co-Founder, Core Technology Team Member
Abhijit Biswas -- Co-Founder and Chief Technology Officer
Christopher Joyce -- COO / CF0
Mark Kotfila -- Lead, Strategic Partnerships
Chelsey Ryan -- Commercialization Lead
Taylor Tobin -- Lead Mechanical Engineer
Jose Wong -- Chief Product Officer
Edward Adelson -- Co-Founder, Core Technology Team Member
Abhijit Biswas -- Co-Founder and Chief Technology Officer
Christopher Joyce -- COO / CF0
Mark Kotfila -- Lead, Strategic Partnerships
Chelsey Ryan -- Commercialization Lead
Taylor Tobin -- Lead Mechanical Engineer
Jose Wong -- Chief Product Officer
Company News
There are no news available.